By reading the comments I wonder if perhaps OAI & ANT are not going to be “model” companies and they are going to be the ones innovating in many fronts and cashing in for the benefits of those advancements…
What I’m trying to say here is, what if, they are staying closed strategically so they keep their most advanced models close to their chest until they make an incredible discovery. Say they cure cancer. In this case, they are taking that IP collaborating with big pharma and cashing in on the upside of such discovery.
So, what if on top of being just another enterprise and consumer product that accelerates the way we all work and live, it also becomes this factory of breakthroughs and that’s where open source models can’t compete with them.
What I’m trying to say here is, what if, they are staying closed strategically so they keep their most advanced models close to their chest until they make an incredible discovery. Say they cure cancer. In this case, they are taking that IP collaborating with big pharma and cashing in on the upside of such discovery.
So, what if on top of being just another enterprise and consumer product that accelerates the way we all work and live, it also becomes this factory of breakthroughs and that’s where open source models can’t compete with them.
Just speculating…